Dental Practice Valuation Checklist for Selling My Practice

Key Takeaways for 2026 Dental Practice Sales

• Preparation that matches buyer diligence standards can help a one-time seller face professionals who negotiate transactions every week.
• Normalized EBITDA analysis forms the foundation of many 2026 valuations and usually requires 3 years of tax returns, monthly financials, and documented add-backs that can withstand quality-of-earnings review.
• Owner compensation normalization and discretionary expense add-backs can be some of the largest EBITDA adjustments and may add $80,000–$300,000 to practice value when clearly documented.
• Lease terms under 5 years remaining, high owner dependence, and concentrated payer mix can each compress valuation multiples even when collections look strong.
• McLerran & Associates converts buyer checklists into CPA-led valuations and runs structured processes that can deliver 85–90% transaction rates and approximately 30% higher valuations; connect with the team for a confidential valuation conversation to begin.

13-Item Dental Practice Valuation Checklist

1. Three years of business tax returns plus year-to-date financials. Buyers and lenders compare tax filings to internal profit-and-loss statements to spot gaps or inconsistencies. SBA 7(a) lenders typically require the 3 most recent years of business tax returns and may use IRS Form 4506-C or Form 8821 to confirm that submitted documents match IRS records. This step matters for both private buyers and institutional groups.
2. Three years of monthly profit-and-loss statements and balance sheets. Month-by-month P&Ls show collections consistency and highlight revenue spikes in the final year, which buyers often discount. Both buyer types review these trends closely.
3. 12 months of business bank statements. Buyers use bank statements to verify average monthly cash position, working-capital sufficiency, and whether reported collections match deposits. Both private-buyer lenders and institutional quality-of-earnings teams request this information.
4. Owner compensation normalization. This category is often the largest and most debated add-back in a dental transaction. Owner-doctor production compensation is usually reset to a market clinical rate for a general practitioner, and this adjustment can create $80,000–$300,000 in normalized EBITDA uplift for solo-producer practices. Payroll records and a clear market-rate explanation support every dollar of this adjustment. Institutional buyers that apply EBITDA multiples tend to focus heavily on this step.
5. Personal and discretionary expenses run through the practice. Personal expenses such as vehicles, travel, meals, family payroll, and personal insurance often total $30,000 to $150,000 per year in dental practices. Buyers commonly request credit card statements during quality-of-earnings review. Both buyer types look for clear documentation.
6. Family member payroll above market rate. When family members receive above-market pay, buyers typically normalize compensation by removing the excess, which can increase EBITDA, and they review every W-2 during diligence. Document each family member’s role, hours, and pay compared with local market rates.
7. One-time and non-recurring expenses. Legal settlements, pre-sale consulting, unusual equipment repairs, and similar items often qualify as add-backs because they are not expected to recur. Non-recurring items such as one-time legal fees usually qualify as add-backs. Both buyer types expect invoices or other support for each item.
8. Related-party rent adjustment to market. When the practice owner also owns the building and charges rent above or below market, buyers adjust the lease rate to a typical third-party level. Real estate is then negotiated separately from practice enterprise value. This adjustment matters for both private and institutional buyers.
9. Production and collections reports by provider and procedure code (trailing 24 months). Buyers usually request production reports by doctor and procedure, collections reports, adjustments and write-offs, and aging reports pulled directly from the practice management software. Provider-level data highlights owner dependence, which can be a major valuation factor for both buyer types and especially for institutional buyers focused on earnings transferability.
10. Active patient count and hygiene recall metrics. Active patients are typically defined as those seen within the prior 18 months. New patient flow can be a key benchmark for a general practice, especially when the acquisition source is tracked. Hygiene revenue above 25% of collections is a common metric in dental practice due diligence. Institutional buyers often weigh hygiene metrics more heavily because they relate to recurring revenue.
11. Payer mix analysis by carrier. Payer mix can be a major driver of valuation differences, with fee-for-service dominant practices often trading at the top of published ranges and Medicaid-heavy practices usually trading at lower multiples. Provide a breakdown of fee-for-service, PPO, and Medicaid as a share of collections. Heavy reliance on a single plan can concern both lenders and buyers.
12. Office lease with all amendments, renewal options, and assignment consent language. A dental practice lease with fewer than 5–10 years remaining can be a deal-breaker that reduces buyer interest and sale price; practices ideally carry 10–15+ years of remaining term or renewal options to support lender requirements. Assignment consent, which is the landlord’s written permission to transfer the lease, is a standard diligence item for both private buyers and institutional groups.
13. Staff roster with tenure, compensation, and employment agreements. Long-tenured teams that fit the practice culture can support stronger pricing due to higher productivity, while high staff turnover may result in lower valuation multiples. Include hygienist rosters with production data, front office tenure, and any associate doctor agreements. Staff stability matters to both buyer types, and institutional groups often review associate productivity trends in detail.

Dental Practice Valuation Worksheet You Can Fill In

The table below mirrors the 13-item checklist above. Use it to organize trailing twelve-month (TTM) figures alongside 3-year averages, which are the two time horizons buyers and lenders often use to review earnings quality and trends.

Checklist Item	TTM Figure / Status	Year 1 (3 yrs ago)	Year 2 (2 yrs ago)	Year 3 (Prior year)
1. Business tax returns / YTD financials	Collected: Y/N	Filed: Y/N	Filed: Y/N	Filed: Y/N
2. Monthly P&Ls and balance sheets	Collected: Y/N	Available: Y/N	Available: Y/N	Available: Y/N
3. Bank statements (12 months)	Collected: Y/N	—	—	—
4. Owner compensation normalization ($)	$___	$___	$___	$___
5. Personal / discretionary add-backs ($)	$___	$___	$___	$___
6. Family payroll above market ($)	$___	$___	$___	$___
7. One-time / non-recurring expenses ($)	$___	$___	$___	$___
8. Related-party rent adjustment ($)	$___	$___	$___	$___
9. Collections by provider / procedure ($)	$___	$___	$___	$___
10. Active patient count / hygiene recall (%)	___pts / ___%	___pts / ___%	___pts / ___%	___pts / ___%
11. Payer mix: FFS / PPO / Medicaid (%)	__% / __% / __%	__% / __% / __%	__% / __% / __%	__% / __% / __%
12. Lease term remaining / assignment consent	___ yrs / Y/N	—	—	—
13. Staff tenure / associate agreements	Avg ___ yrs / Y/N	—	—	—
Normalized EBITDA (calculated)	$___	$___	$___	$___

Owners who want help deciding which add-backs fit their situation can request a complimentary normalization review from McLerran & Associates’ CPA-led team, which can include a diligence-grade schedule built from the worksheet.

Side-by-Side Valuation Comparison: Private Buyer vs. Institutional Markets

Once you calculate normalized EBITDA using the worksheet, the next step is understanding how different buyer types may interpret that same number. The same normalized EBITDA figure can produce very different outcomes depending on who sits at the table. Private buyers, usually individual dentists using SBA or conventional loans, are limited by what the practice’s cash flow can support after their own income and debt payments. Private-buyer dental practice transactions in 2026 are typically valued at 65–85% of annual gross collections for general practices.

Institutional buyers often apply EBITDA multiples that reflect scale benefits and competitive bidding. In 2026, dental practices can trade at roughly 5x–8x EBITDA for smaller institutional tuck-ins or add-ons, while larger or multi-location practices may command 8x–11x or more.

Metric	Private Buyer (Doctor-to-Doctor)	Institutional Buyer
Primary valuation method	Collections-based (65–85% range)	5x–11x+ normalized EBITDA depending on size tier
Deal structure	Typically all-cash at close, 60–120 day transition	60–75% cash at close, 15–30% rollover equity, 5–15% earnout
Payer mix sensitivity	Primarily cash-flow serviceability, less formal payer-mix review	Lower multiples for Medicaid-heavy practices
Owner dependence impact	Valuation impact when the owner produces a high share of revenue	Compressed multiples plus greater escrow, earnout, or rollover equity requirements
Post-close commitment	Typically 60–120 days	Typically a multi-year working agreement

Because McLerran & Associates regularly works on both transition paths, the firm can prepare a true side-by-side valuation that estimates a practice’s worth in each market so owners choose a path with clearer information.

What Reduces Value: Operational, Structural, and Revenue Risks

Several factors can move a practice down a valuation band or trigger buyer discounts even when collections look strong. These issues often fall into 3 groups: operational risk, structural constraints, and revenue quality. Understanding them before going to market can give owners time to address or document them, with owner dependence and lease terms often having the greatest impact.

• High owner dependence. Practices where the owner produces 90% or more of revenue may see lower valuations than associate-led practices. Adding even one producing associate can reduce this risk and may support stronger multiples.
• Short or unfavorable lease terms. As noted in the checklist above, insufficient remaining lease term can create post-acquisition occupancy risk that both institutional and private buyers discount heavily. Missing assignment consent language is also a frequent deal-stopper.
• Medicaid or single-payer concentration. Heavy reliance on a single payer or a Medicaid-heavy mix can compress valuation multiples and often raises underwriting concerns for lenders and buyers.
• Declining or low active patient count. Declining active patient count, even when collections appear stable, can signal future revenue risk that buyers discount during due diligence, often by restating counts to the ADA’s 18-month standard.
• Aging or deferred equipment. Buyers may subtract expected annual capital expenditures from adjusted cash flow when estimating value, which can reduce price for practices that require significant investment in new equipment or IT beyond routine maintenance.
• High staff turnover. Practices with frequent staff turnover or heavy use of temporary labor are often viewed as less predictable and may receive lower valuation multiples.
• Poorly documented or contested add-backs. Buyer quality-of-earnings teams often apply a defensibility test to each add-back and reduce those that lack contemporaneous documentation. Invoices, payroll records, or bank statements usually support each normalization.

Measuring Preparation: Signals Your Valuation Work Is Holding Up

A well-prepared seller can track several practical indicators that suggest their preparation is meeting buyer expectations.

• Normalized EBITDA holds through a buyer’s quality-of-earnings review without major downward price changes.
• Multiple qualified buyers submit offers, which creates competitive tension instead of relying on a single unsolicited offer. Practices taken to market through a structured multiple-buyer process have received final sale values averaging 50% above initial unsolicited offers.
• The letter of intent (LOI), which is the preliminary agreement that sets price and structure, reflects the seller’s normalized EBITDA rather than a buyer-set anchor.
• Individual-buyer dental practice sales typically close in 60–120 days, while DSO deals often take 3–6 months because of corporate diligence.
• The deal does not get re-traded, meaning the agreed price is not renegotiated downward after diligence begins.

Frequently Asked Questions

What is a dental practice valuation worksheet and how do I use one?

A dental practice valuation worksheet is a structured document that organizes the financial and operational data buyers and lenders review during due diligence. It usually includes columns for trailing twelve-month figures and 3-year historical data across key metrics such as gross collections, normalized EBITDA, active patient count, payer mix, and major add-back categories. The worksheet can help the seller spot documentation gaps before going to market and gives an advisor the raw data needed to build a defensible normalized EBITDA analysis. The 13-item table in this article offers a starting framework, and a CPA-led advisor can tailor it to the practice’s entity type, specialty, and likely transition path.

What is the dental practice valuation formula used in 2026?

There is no single universal formula, and the method often depends on buyer type and practice size. For private, doctor-to-doctor transactions, practices are commonly valued at a percentage of annual gross collections, often around the 65–85% range for general practices, or as a multiple of seller’s discretionary earnings (SDE). SDE adds back the owner’s full compensation and discretionary expenses to net income. For DSO and institutional buyers, the standard approach is a multiple of normalized EBITDA, which means reported earnings adjusted for interest, taxes, depreciation, amortization, owner compensation normalization, personal expenses, one-time costs, and related-party items. The multiple applied to normalized EBITDA can vary by practice size, specialty, payer mix, owner dependence, and market conditions. A $100,000 change in normalized EBITDA can move enterprise value by several hundred thousand dollars at common multiples, so the normalization work itself can be where much of the value is created or lost.

What are the tax implications of a dental practice valuation and sale?

Tax outcomes can vary widely based on deal structure, entity type, and how the purchase price is allocated across assets. In a DSO affiliation, a meaningful share of proceeds, especially amounts allocated to goodwill, may qualify for long-term capital gains treatment instead of ordinary income rates, which can create a significant after-tax difference. Rollover equity received in a DSO deal is generally not taxed at closing and usually becomes taxable when that equity is later sold or recapitalized. Earnout payments are typically taxed as ordinary income in the year they are received. Asset sales and stock sales carry different tax profiles for both buyer and seller, and the allocation of purchase price among equipment, tangible assets, non-compete agreements, and goodwill influences how each dollar is taxed. These questions are fact-specific, so consulting a qualified dental CPA or tax advisor before structuring any transaction can be helpful. McLerran & Associates prepares multi-year, multi-structure financial forecasts that model after-tax proceeds across deal types and time horizons so owners can compare options with clearer information.

Is there a dental practice valuation calculator I can use?

Online dental practice valuation calculators can provide a rough directional estimate, but they usually do not replace a diligence-grade analysis. Many calculators apply a fixed multiple to gross collections or a simplified EBITDA figure without reflecting normalizations such as owner compensation, personal expenses, one-time costs, and related-party rent that can move the defensible number by hundreds of thousands of dollars. Calculators also cannot capture specialty-specific demand, regional market conditions, payer mix dynamics, or the competitive tension that a structured bid process can create. A free calculator estimate that has not been tested against buyer scrutiny can quietly anchor expectations. McLerran & Associates offers a comprehensive, CPA-led practice valuation at the start of each engagement so the valuation figure is designed to hold when buyers review the details.

Next Step: Talk Through Your 2026 Practice Valuation

Owners sell once, and the data gathered before going to market can quietly set the price. McLerran & Associates uses the same checklist buyers rely on to build a CPA-led valuation, then runs a structured, auction-like process among a vetted pool of qualified buyers. The result is the transaction success and valuation premium described at the outset, supported by approximately 2,000 successful practice sales and more than $2 billion in closed transaction volume.

Whether the right path is a doctor-to-doctor sale or an institutional affiliation, a clear understanding of what your practice may be worth in both markets can be a useful first step. Reach out to McLerran & Associates to begin a confidential valuation discussion or call (512) 900-7989, email info@dentaltransitions.com, or visit the contact page to get started.

Owners who are not ready to sell yet can still prepare by learning how buyers think. The McLerran M&A Summit on October 29–30, 2026 is a dental-only event designed for owners who are still deciding. Attendees receive 4 CE credits and a complimentary practice valuation, noted as a $2,500 value. Contact McLerran & Associates to learn more about the Summit and reserve a seat.